Sodium-glucose cotransporter-2 inhibitor
Showing 1 - 25 of >10,000
Cardiorenal Syndrome Trial in New Haven (Dapagliflozin)
Not yet recruiting
- Cardiorenal Syndrome
-
New Haven, ConnecticutYale New Haven Hospital
Oct 26, 2023
Diabetes, Cellular Senescence, Sodium-Glucose Transporter 2 Inhibitors Trial in Seoul (SGLT2 inhibitor, Glimepiride)
Not yet recruiting
- Diabetes Mellitus
- +2 more
- SGLT2 inhibitor
- Glimepiride
-
Seoul, Korea, Republic ofYonsei University College of Medicine
Aug 1, 2023
MDD Trial in New York (Empagliflozin)
Not yet recruiting
- Major Depressive Disorder
-
New York, New YorkNYU Langone Health
Feb 24, 2023
Sodium Glucose Cotransporter 2 Inhibitiors on Left Ventricular
Not yet recruiting
- SGLT2 Inhibitiors Remodeling Effect
- Chronic Heart Disease
- Sodium-glucose cotransporter 2 inhibitor
- (no location specified)
Nov 14, 2023
SGLT2 Inhibition in Heart Failure
Recruiting
- Heart Failure
- Sodium-glucose cotransporter 2 inhibitor
-
Belfast, United KingdomBelfast Health and Social Care Trust
Nov 15, 2023
Tricuspid Regurgitation Trial in Seoul (Dapagliflozin Propanediol Hydrate 12.3 mg)
Recruiting
- Tricuspid Regurgitation
- Dapagliflozin Propanediol Hydrate 12.3 mg
-
Seoul, Korea, Republic ofSamsung Medical Center
Jan 9, 2023
Fatty Liver Disease Trial in Tainan (Canagliflozin 100mg)
Completed
- Fatty Liver Disease
- Canagliflozin 100mg
-
Tainan, TaiwanNational Cheng Kung University Hospital
Feb 28, 2023
Sleep Apnea Trial in New Haven, Cleveland (Ertugliflozin 15 mg, Placebo)
Not yet recruiting
- Sleep Apnea
- Ertugliflozin 15 mg
- Placebo
-
New Haven, Connecticut
- +1 more
Jan 24, 2023
Sodium-glucose Cotransporter 2 Inhibitors+Sacubitril/Valsartan
Recruiting
- Heart Failure
- +2 more
- SGLT2 inhibitor
-
Roma, RM, ItalyFondazione Policlinico Universitario A. Gemelli IRCSS
Jun 28, 2023
Cystinuria Trial in San Francisco (Dapagliflozin)
Not yet recruiting
- Cystinuria
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 13, 2022
Heart Failure With Preserved Ejection Fraction Trial in Porto (Dapagliflozin, Spironolactone, Spironolactone + Dapagliflozin)
Recruiting
- Heart Failure With Preserved Ejection Fraction
- Dapagliflozin
- +2 more
-
Porto, Portugal
- +1 more
Jan 12, 2023
Second-line Therapies for Type 2 Diabetes and Moderate
Enrolling by invitation
- Type 2 Diabetes
- Cardiac Disease
- Glucagon like peptide 1 receptor agonist
- +3 more
-
Rochester, MinnesotaMayo Clinic Rochester
Jan 26, 2022
Heart Failure With Reduced Ejection Fraction Trial in Porto (Sacubitril-valsartan, SGLT2 inhibitor)
Recruiting
- Heart Failure With Reduced Ejection Fraction
- Sacubitril-valsartan
- SGLT2 inhibitor
-
Porto, Portugal
- +3 more
Aug 9, 2023
Fatty Liver, Nonalcoholic Trial (SGLT2 inhibitor)
Not yet recruiting
- Fatty Liver, Nonalcoholic
- SGLT2 inhibitor
- (no location specified)
Oct 31, 2023
SGLT-2 Inhibitors in the Treatment of Ascites
Recruiting
- Ascites Hepatic
- +2 more
- SGLT2 inhibitor
-
Palermo, Italy
- +1 more
Aug 11, 2023
Diabetes, Type 2, Endothelial Dysfunction Trial in Boston (Dapagliflozin, Placebo)
Recruiting
- Diabetes Mellitus, Type 2
- Endothelial Dysfunction
- Dapagliflozin
- Placebo
-
Boston, MassachusettsBU School of Medicine Evans 748
Jun 1, 2022
Acute Kidney Injury, Cardiac Surgery, Sodium-Glucose Transporter 2 Inhibitor Trial in Netherlands (Dapagliflozin 10 MG Oral
Not yet recruiting
- Acute Kidney Injury
- +2 more
- Dapagliflozin 10 MG Oral Tablet [Farxiga]
- Placebo
-
Amsterdam, Netherlands
- +5 more
Oct 18, 2022
Glomerulonephritis, Immunoglobulin A Nephropathy Trial (Corticosteroid, Renin-angiotensin sytem blockers, Sodium-glucose
Not yet recruiting
- Glomerulonephritis
- Immunoglobulin A Nephropathy
- Corticosteroid
- +2 more
- (no location specified)
Oct 13, 2021
Acute Kidney Injury, Kidney Failure, Sodium Glucose Cotransporter-2 Inhibitors Trial in Newtown (SGLT2 inhibitor or matched )
Not yet recruiting
- Acute Kidney Injury
- +2 more
- SGLT2 inhibitor or matched placebo
-
Newtown, New South Wales, AustraliaThe George Institute for Global Health
Jul 19, 2022
Renal Insufficiency, Chronic Trial in Mansoura, Tanta (Metformin, Empagliflozin, Standard therapy)
Recruiting
- Renal Insufficiency, Chronic
- Metformin
- +2 more
-
Mansoura, Dakahlia Governorate, Egypt
- +1 more
May 12, 2022
Heart Failure Trial in Glasgow (Dapagliflozin 10 MG Oral Tablet, Metolazone Tablets)
Recruiting
- Heart Failure
- Dapagliflozin 10 MG Oral Tablet
- Metolazone Tablets
-
Glasgow, Strathclyde, United Kingdom
- +1 more
Apr 27, 2021
Fatty Liver Disease Trial (Empagliflozin 10 MG)
Not yet recruiting
- Fatty Liver Disease
- Empagliflozin 10 MG
- (no location specified)
Jan 19, 2023
Blood Pressure, Salt; Excess, Diabete Type 2 Trial in Pisa (Hypersodic/Hyposodic diet)
Recruiting
- Blood Pressure
- +2 more
- Hypersodic/Hyposodic diet
-
Pisa, PI, ItalyAzienda Ospedaliero-Universitaria Pisana
Aug 23, 2023
Cystinuria Trial in San Francisco (Dapagliflozin)
Recruiting
- Cystinuria
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 4, 2022
PCO Trial in Bani Suwayf (Dapagliflozin 5 MG, Metformin Hydrochloride 1000 MG, Dapagliflozin/Metformin)
Recruiting
- PCO
- Dapagliflozin 5 MG
- +2 more
-
Banī Suwayf, Beni Suef, EgyptBeni-suef university
Oct 26, 2022